Edward Melanson
Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Metabolism | 53 | 2025 | 919 | 7.540 |
Why?
| | Exercise | 48 | 2025 | 2043 | 4.530 |
Why?
| | Weight Loss | 27 | 2025 | 776 | 4.410 |
Why?
| | Energy Intake | 30 | 2025 | 484 | 3.410 |
Why?
| | Obesity | 30 | 2025 | 2982 | 2.360 |
Why?
| | Fasting | 9 | 2025 | 280 | 2.140 |
Why?
| | Calorimetry, Indirect | 20 | 2024 | 84 | 2.110 |
Why?
| | Caloric Restriction | 8 | 2025 | 123 | 2.100 |
Why?
| | Thermogenesis | 6 | 2024 | 44 | 1.950 |
Why?
| | Calorimetry | 10 | 2024 | 70 | 1.570 |
Why?
| | Weight Reduction Programs | 6 | 2025 | 116 | 1.540 |
Why?
| | Overweight | 13 | 2025 | 557 | 1.520 |
Why?
| | Adipose Tissue, Brown | 3 | 2024 | 53 | 1.460 |
Why?
| | Breakfast | 2 | 2020 | 20 | 1.350 |
Why?
| | Sleep | 16 | 2024 | 753 | 1.300 |
Why?
| | Eating | 12 | 2022 | 379 | 1.290 |
Why?
| | Meals | 5 | 2020 | 125 | 1.250 |
Why?
| | Dietary Fats | 7 | 2019 | 304 | 1.250 |
Why?
| | Body Composition | 20 | 2025 | 679 | 1.160 |
Why?
| | Resistance Training | 6 | 2024 | 163 | 1.070 |
Why?
| | Accelerometry | 5 | 2025 | 99 | 1.050 |
Why?
| | Oxygen Consumption | 13 | 2025 | 695 | 1.030 |
Why?
| | Diet | 9 | 2025 | 1274 | 0.940 |
Why?
| | Basal Metabolism | 8 | 2024 | 61 | 0.910 |
Why?
| | Circadian Rhythm | 13 | 2024 | 468 | 0.880 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2024 | 212 | 0.850 |
Why?
| | Premenopause | 3 | 2020 | 131 | 0.840 |
Why?
| | Adult | 72 | 2025 | 37630 | 0.840 |
Why?
| | Oxygen Isotopes | 5 | 2021 | 25 | 0.830 |
Why?
| | Estradiol | 2 | 2018 | 518 | 0.830 |
Why?
| | Behavior Therapy | 3 | 2021 | 258 | 0.830 |
Why?
| | Monitoring, Physiologic | 6 | 2024 | 267 | 0.820 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 134 | 0.820 |
Why?
| | Lipid Metabolism | 5 | 2012 | 512 | 0.790 |
Why?
| | Dietary Carbohydrates | 8 | 2019 | 155 | 0.760 |
Why?
| | Humans | 120 | 2025 | 136768 | 0.750 |
Why?
| | Female | 85 | 2025 | 72796 | 0.750 |
Why?
| | Dietary Proteins | 7 | 2019 | 135 | 0.740 |
Why?
| | Water | 4 | 2024 | 457 | 0.740 |
Why?
| | Body Weight | 11 | 2021 | 985 | 0.730 |
Why?
| | Time Factors | 21 | 2025 | 6808 | 0.720 |
Why?
| | Sleep Deprivation | 9 | 2021 | 174 | 0.720 |
Why?
| | Walking | 9 | 2025 | 523 | 0.710 |
Why?
| | Ovary | 3 | 2020 | 221 | 0.690 |
Why?
| | Middle Aged | 45 | 2025 | 33228 | 0.670 |
Why?
| | Body Mass Index | 20 | 2025 | 2375 | 0.660 |
Why?
| | Cancer Survivors | 2 | 2022 | 280 | 0.660 |
Why?
| | Reference Standards | 1 | 2020 | 186 | 0.650 |
Why?
| | Estrogens | 2 | 2024 | 367 | 0.650 |
Why?
| | Male | 82 | 2025 | 67311 | 0.650 |
Why?
| | Weight Gain | 10 | 2024 | 519 | 0.630 |
Why?
| | Exercise Test | 10 | 2024 | 625 | 0.620 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 41 | 0.590 |
Why?
| | Exercise Tolerance | 3 | 2025 | 279 | 0.580 |
Why?
| | Pulmonary Gas Exchange | 2 | 2018 | 121 | 0.580 |
Why?
| | Appetite | 5 | 2025 | 69 | 0.570 |
Why?
| | Young Adult | 25 | 2025 | 13129 | 0.570 |
Why?
| | Fats | 3 | 2009 | 17 | 0.550 |
Why?
| | Physical Exertion | 5 | 2018 | 215 | 0.540 |
Why?
| | Isotope Labeling | 1 | 2017 | 80 | 0.540 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2019 | 165 | 0.520 |
Why?
| | Rest | 4 | 2018 | 121 | 0.490 |
Why?
| | Leuprolide | 1 | 2015 | 20 | 0.480 |
Why?
| | Muscle, Skeletal | 6 | 2014 | 1710 | 0.470 |
Why?
| | Oxidation-Reduction | 11 | 2019 | 1059 | 0.470 |
Why?
| | Exercise Therapy | 3 | 2025 | 436 | 0.440 |
Why?
| | Hunger | 2 | 2021 | 44 | 0.440 |
Why?
| | Cold Temperature | 3 | 2024 | 178 | 0.440 |
Why?
| | Autonomic Nervous System Diseases | 2 | 2025 | 36 | 0.440 |
Why?
| | Mass Spectrometry | 1 | 2017 | 738 | 0.430 |
Why?
| | Cross-Over Studies | 9 | 2022 | 562 | 0.430 |
Why?
| | Arthroplasty, Replacement, Knee | 3 | 2025 | 359 | 0.420 |
Why?
| | Fatty Acids | 3 | 2012 | 442 | 0.390 |
Why?
| | Breast Neoplasms | 2 | 2022 | 2234 | 0.390 |
Why?
| | Parkinson Disease | 3 | 2025 | 490 | 0.390 |
Why?
| | Monitoring, Ambulatory | 4 | 2017 | 87 | 0.390 |
Why?
| | Appetite Regulation | 3 | 2021 | 31 | 0.370 |
Why?
| | Temperature | 1 | 2014 | 675 | 0.360 |
Why?
| | Thinness | 1 | 2012 | 91 | 0.360 |
Why?
| | Deglutition | 5 | 2014 | 72 | 0.360 |
Why?
| | Heart Rate | 7 | 2025 | 820 | 0.340 |
Why?
| | Wearable Electronic Devices | 2 | 2024 | 53 | 0.340 |
Why?
| | Feeding Behavior | 5 | 2025 | 648 | 0.330 |
Why?
| | Activities of Daily Living | 4 | 2018 | 413 | 0.330 |
Why?
| | Perception | 1 | 2013 | 359 | 0.330 |
Why?
| | Melatonin | 5 | 2023 | 150 | 0.320 |
Why?
| | Work Schedule Tolerance | 3 | 2020 | 49 | 0.310 |
Why?
| | Carbon Dioxide | 2 | 2010 | 267 | 0.310 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 16 | 0.300 |
Why?
| | Food | 3 | 2024 | 160 | 0.300 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 153 | 0.300 |
Why?
| | Posture | 5 | 2016 | 186 | 0.290 |
Why?
| | Adaptation, Psychological | 1 | 2013 | 651 | 0.290 |
Why?
| | Reproducibility of Results | 13 | 2023 | 3264 | 0.280 |
Why?
| | Weight Lifting | 2 | 2009 | 33 | 0.270 |
Why?
| | Spectrum Analysis | 3 | 2019 | 91 | 0.270 |
Why?
| | Menopause | 2 | 2022 | 319 | 0.270 |
Why?
| | Wakefulness | 5 | 2020 | 125 | 0.260 |
Why?
| | Anorexia Nervosa | 2 | 2005 | 88 | 0.260 |
Why?
| | Cardiovascular Diseases | 3 | 2024 | 2104 | 0.250 |
Why?
| | Carbohydrate Metabolism | 3 | 2006 | 59 | 0.250 |
Why?
| | Regression Analysis | 4 | 2025 | 1022 | 0.250 |
Why?
| | Deuterium | 4 | 2021 | 99 | 0.240 |
Why?
| | Metabolic Syndrome | 1 | 2009 | 354 | 0.240 |
Why?
| | Shoes | 5 | 2017 | 18 | 0.240 |
Why?
| | Calcium, Dietary | 1 | 2005 | 57 | 0.240 |
Why?
| | Adolescent | 15 | 2025 | 21382 | 0.240 |
Why?
| | Delay Discounting | 1 | 2025 | 23 | 0.230 |
Why?
| | Ghrelin | 5 | 2025 | 36 | 0.230 |
Why?
| | Mastication | 4 | 2014 | 13 | 0.230 |
Why?
| | Physical Endurance | 3 | 2009 | 275 | 0.230 |
Why?
| | Sports Equipment | 1 | 2004 | 9 | 0.230 |
Why?
| | Gastrointestinal Microbiome | 2 | 2023 | 697 | 0.220 |
Why?
| | Eyeglasses | 1 | 2024 | 7 | 0.220 |
Why?
| | Signal Processing, Computer-Assisted | 3 | 2017 | 143 | 0.220 |
Why?
| | Double-Blind Method | 3 | 2019 | 1981 | 0.220 |
Why?
| | Osteoarthritis, Knee | 2 | 2025 | 254 | 0.210 |
Why?
| | Cardiorespiratory Fitness | 2 | 2024 | 55 | 0.210 |
Why?
| | Physical Fitness | 2 | 2013 | 208 | 0.200 |
Why?
| | HIV Integrase | 1 | 2024 | 70 | 0.200 |
Why?
| | HIV Integrase Inhibitors | 1 | 2024 | 70 | 0.200 |
Why?
| | Biomarkers | 5 | 2024 | 4144 | 0.200 |
Why?
| | Motor Activity | 3 | 2019 | 717 | 0.200 |
Why?
| | Puberty | 2 | 2014 | 146 | 0.190 |
Why?
| | Positron-Emission Tomography | 1 | 2024 | 293 | 0.190 |
Why?
| | Insulin Resistance | 4 | 2019 | 1203 | 0.190 |
Why?
| | Circadian Clocks | 2 | 2019 | 50 | 0.190 |
Why?
| | Peptide YY | 4 | 2025 | 17 | 0.190 |
Why?
| | Diet, Fat-Restricted | 3 | 2011 | 79 | 0.180 |
Why?
| | Bone Density | 2 | 2015 | 487 | 0.180 |
Why?
| | France | 1 | 2021 | 33 | 0.180 |
Why?
| | Aging | 2 | 2012 | 1864 | 0.180 |
Why?
| | Bone Remodeling | 1 | 2021 | 75 | 0.170 |
Why?
| | Analysis of Variance | 6 | 2021 | 1316 | 0.170 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1032 | 0.170 |
Why?
| | Fruit | 1 | 2021 | 139 | 0.170 |
Why?
| | Glucose | 2 | 2024 | 1019 | 0.170 |
Why?
| | Vegetables | 1 | 2021 | 156 | 0.170 |
Why?
| | Nitrogen | 2 | 2012 | 168 | 0.160 |
Why?
| | Starch | 1 | 2019 | 22 | 0.160 |
Why?
| | Nutritive Value | 1 | 2019 | 37 | 0.160 |
Why?
| | Contraceptive Agents | 1 | 2020 | 66 | 0.160 |
Why?
| | Cross-Sectional Studies | 6 | 2023 | 5423 | 0.160 |
Why?
| | Sweating | 1 | 2019 | 40 | 0.160 |
Why?
| | Amputees | 1 | 2021 | 95 | 0.160 |
Why?
| | Inpatients | 1 | 2023 | 496 | 0.150 |
Why?
| | Parathyroid Hormone | 1 | 2019 | 108 | 0.150 |
Why?
| | Aged | 14 | 2025 | 23794 | 0.150 |
Why?
| | Adipocytes | 2 | 2018 | 222 | 0.150 |
Why?
| | Body Temperature | 2 | 2010 | 221 | 0.150 |
Why?
| | Telerehabilitation | 1 | 2019 | 37 | 0.150 |
Why?
| | Hospitals | 1 | 2023 | 685 | 0.150 |
Why?
| | Proof of Concept Study | 1 | 2018 | 78 | 0.150 |
Why?
| | Postprandial Period | 3 | 2020 | 107 | 0.140 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 549 | 0.140 |
Why?
| | High-Intensity Interval Training | 1 | 2018 | 25 | 0.140 |
Why?
| | Guideline Adherence | 1 | 2022 | 546 | 0.140 |
Why?
| | Brain Mapping | 3 | 2016 | 504 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2019 | 204 | 0.140 |
Why?
| | Pilot Projects | 5 | 2022 | 1692 | 0.140 |
Why?
| | Postmenopause | 1 | 2019 | 365 | 0.130 |
Why?
| | Artificial Limbs | 1 | 2021 | 199 | 0.130 |
Why?
| | Brain | 4 | 2025 | 2664 | 0.130 |
Why?
| | Algorithms | 4 | 2015 | 1689 | 0.130 |
Why?
| | Diet, Reducing | 3 | 2025 | 89 | 0.130 |
Why?
| | Computer Storage Devices | 1 | 2016 | 2 | 0.130 |
Why?
| | Self Report | 1 | 2021 | 822 | 0.130 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 175 | 0.130 |
Why?
| | Gait | 2 | 2017 | 296 | 0.130 |
Why?
| | Odds Ratio | 1 | 2019 | 1065 | 0.130 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1231 | 0.130 |
Why?
| | Homeostasis | 3 | 2019 | 619 | 0.120 |
Why?
| | Needs Assessment | 1 | 2018 | 372 | 0.120 |
Why?
| | Life Style | 2 | 2021 | 487 | 0.120 |
Why?
| | Estrogens, Conjugated (USP) | 1 | 2015 | 49 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 762 | 0.120 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 315 | 0.120 |
Why?
| | Metabolomics | 1 | 2020 | 678 | 0.110 |
Why?
| | Blood Glucose | 4 | 2020 | 2181 | 0.110 |
Why?
| | Sleep Stages | 1 | 2014 | 47 | 0.110 |
Why?
| | Skin | 1 | 2019 | 751 | 0.110 |
Why?
| | Leptin | 4 | 2025 | 236 | 0.110 |
Why?
| | Triglycerides | 2 | 2019 | 524 | 0.110 |
Why?
| | Health Status | 1 | 2019 | 788 | 0.110 |
Why?
| | Diet Records | 2 | 2014 | 83 | 0.110 |
Why?
| | Proteome | 1 | 2018 | 472 | 0.100 |
Why?
| | Calcium | 1 | 2019 | 1197 | 0.100 |
Why?
| | Muscle Fatigue | 1 | 2014 | 102 | 0.100 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2013 | 21 | 0.100 |
Why?
| | Task Performance and Analysis | 1 | 2014 | 183 | 0.100 |
Why?
| | Cell Phone | 1 | 2014 | 75 | 0.100 |
Why?
| | Sound Spectrography | 2 | 2009 | 18 | 0.100 |
Why?
| | Surveys and Questionnaires | 3 | 2023 | 5742 | 0.100 |
Why?
| | Insulin | 5 | 2020 | 2406 | 0.100 |
Why?
| | Hydrogen | 1 | 2012 | 70 | 0.100 |
Why?
| | Urinalysis | 1 | 2012 | 77 | 0.100 |
Why?
| | Blood Pressure | 1 | 2019 | 1774 | 0.100 |
Why?
| | Area Under Curve | 1 | 2013 | 314 | 0.100 |
Why?
| | Lasers | 1 | 2012 | 130 | 0.090 |
Why?
| | Adipose Tissue | 3 | 2011 | 630 | 0.090 |
Why?
| | Hot Temperature | 2 | 2018 | 391 | 0.090 |
Why?
| | Smoking | 1 | 2019 | 1620 | 0.090 |
Why?
| | Case-Control Studies | 4 | 2021 | 3540 | 0.090 |
Why?
| | Aged, 80 and over | 5 | 2021 | 7585 | 0.090 |
Why?
| | Veterans | 4 | 2025 | 1466 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 4 | 2025 | 3555 | 0.090 |
Why?
| | Sex Factors | 2 | 2014 | 2060 | 0.090 |
Why?
| | Nerve Net | 1 | 2013 | 256 | 0.090 |
Why?
| | Physical Phenomena | 1 | 2010 | 13 | 0.080 |
Why?
| | Heart Failure | 1 | 2024 | 2231 | 0.080 |
Why?
| | Prospective Studies | 5 | 2021 | 7572 | 0.080 |
Why?
| | Muscle Proteins | 1 | 2012 | 228 | 0.080 |
Why?
| | Chronic Disease | 3 | 2024 | 1785 | 0.080 |
Why?
| | Collagen Type I | 2 | 2021 | 133 | 0.080 |
Why?
| | Glycerol | 1 | 2009 | 94 | 0.080 |
Why?
| | Diet Surveys | 1 | 2009 | 95 | 0.080 |
Why?
| | Somatotypes | 1 | 2009 | 4 | 0.080 |
Why?
| | Pattern Recognition, Automated | 1 | 2009 | 73 | 0.080 |
Why?
| | Cues | 1 | 2011 | 313 | 0.080 |
Why?
| | Models, Biological | 3 | 2018 | 1773 | 0.080 |
Why?
| | Thermography | 1 | 2009 | 11 | 0.080 |
Why?
| | Spirometry | 1 | 2010 | 281 | 0.080 |
Why?
| | Validation Studies as Topic | 1 | 2009 | 22 | 0.080 |
Why?
| | HIV Infections | 1 | 2024 | 2828 | 0.080 |
Why?
| | Nutritional Requirements | 2 | 2024 | 78 | 0.080 |
Why?
| | Auscultation | 1 | 2008 | 4 | 0.070 |
Why?
| | Age Factors | 2 | 2007 | 3284 | 0.070 |
Why?
| | Cerebral Cortex | 1 | 2011 | 433 | 0.070 |
Why?
| | Kinetics | 1 | 2012 | 1664 | 0.070 |
Why?
| | Healthy Volunteers | 2 | 2019 | 199 | 0.070 |
Why?
| | Respiratory Function Tests | 1 | 2010 | 595 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2012 | 559 | 0.070 |
Why?
| | Colorado | 3 | 2021 | 4518 | 0.070 |
Why?
| | Body Fat Distribution | 1 | 2007 | 49 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1758 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2007 | 159 | 0.070 |
Why?
| | Rats, Wistar | 4 | 2011 | 455 | 0.060 |
Why?
| | Norepinephrine | 1 | 2007 | 204 | 0.060 |
Why?
| | Reference Values | 2 | 2012 | 816 | 0.060 |
Why?
| | Sensitivity and Specificity | 3 | 2012 | 1935 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2518 | 0.060 |
Why?
| | Animals | 7 | 2019 | 36847 | 0.060 |
Why?
| | Telemedicine | 2 | 2025 | 851 | 0.060 |
Why?
| | Patient Selection | 1 | 2009 | 690 | 0.060 |
Why?
| | Dairy Products | 1 | 2005 | 36 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2605 | 0.060 |
Why?
| | Recovery of Function | 2 | 2025 | 652 | 0.060 |
Why?
| | Transcription, Genetic | 1 | 2012 | 1455 | 0.060 |
Why?
| | Polysomnography | 2 | 2020 | 183 | 0.060 |
Why?
| | Photoperiod | 2 | 2019 | 52 | 0.060 |
Why?
| | Gyrus Cinguli | 1 | 2025 | 86 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1462 | 0.060 |
Why?
| | Parasympathetic Nervous System | 1 | 2004 | 27 | 0.060 |
Why?
| | Equipment Design | 2 | 2017 | 521 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 1044 | 0.060 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2004 | 63 | 0.060 |
Why?
| | Shift Work Schedule | 1 | 2024 | 12 | 0.060 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 131 | 0.060 |
Why?
| | Thrombophilia | 1 | 2024 | 83 | 0.050 |
Why?
| | Long QT Syndrome | 1 | 2005 | 70 | 0.050 |
Why?
| | Impulsive Behavior | 1 | 2025 | 149 | 0.050 |
Why?
| | Statistics as Topic | 1 | 2004 | 307 | 0.050 |
Why?
| | Adiposity | 3 | 2016 | 518 | 0.050 |
Why?
| | Reaction Time | 1 | 2025 | 412 | 0.050 |
Why?
| | Walk Test | 1 | 2023 | 76 | 0.050 |
Why?
| | Adiponectin | 1 | 2025 | 244 | 0.050 |
Why?
| | Linear Models | 2 | 2018 | 846 | 0.050 |
Why?
| | Integrases | 1 | 2024 | 120 | 0.050 |
Why?
| | Anaerobic Threshold | 1 | 2002 | 28 | 0.050 |
Why?
| | Sampling Studies | 1 | 2002 | 99 | 0.050 |
Why?
| | Sensation | 1 | 2022 | 53 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2024 | 255 | 0.050 |
Why?
| | Hormones | 2 | 2016 | 142 | 0.050 |
Why?
| | Prefrontal Cortex | 1 | 2025 | 304 | 0.050 |
Why?
| | Self-Management | 1 | 2024 | 166 | 0.050 |
Why?
| | Electromyography | 2 | 2014 | 401 | 0.050 |
Why?
| | Satiation | 1 | 2021 | 24 | 0.050 |
Why?
| | Women's Health | 1 | 2004 | 369 | 0.050 |
Why?
| | Recurrence | 2 | 2019 | 1055 | 0.050 |
Why?
| | Osteocalcin | 1 | 2021 | 37 | 0.050 |
Why?
| | Craving | 1 | 2021 | 39 | 0.050 |
Why?
| | Perimenopause | 1 | 2022 | 63 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 143 | 0.040 |
Why?
| | Muscle Strength | 1 | 2024 | 317 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 402 | 0.040 |
Why?
| | Proteins | 2 | 2006 | 1008 | 0.040 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2021 | 133 | 0.040 |
Why?
| | Absorptiometry, Photon | 2 | 2016 | 254 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 28 | 0.040 |
Why?
| | Disability Evaluation | 1 | 2021 | 290 | 0.040 |
Why?
| | Rats | 4 | 2011 | 5639 | 0.040 |
Why?
| | Bone Resorption | 1 | 2019 | 86 | 0.040 |
Why?
| | Health Behavior | 1 | 2024 | 756 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 31 | 0.040 |
Why?
| | Decision Trees | 1 | 2018 | 93 | 0.040 |
Why?
| | Acidosis | 1 | 2019 | 101 | 0.040 |
Why?
| | Patient Discharge | 1 | 2025 | 894 | 0.040 |
Why?
| | Feces | 1 | 2021 | 483 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2019 | 282 | 0.040 |
Why?
| | Methanol | 1 | 2018 | 38 | 0.040 |
Why?
| | Humidity | 1 | 2018 | 50 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2022 | 951 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2018 | 10744 | 0.030 |
Why?
| | Solvents | 1 | 2018 | 108 | 0.030 |
Why?
| | Research Design | 1 | 2024 | 1127 | 0.030 |
Why?
| | Health Promotion | 1 | 2023 | 734 | 0.030 |
Why?
| | Europe | 1 | 2018 | 413 | 0.030 |
Why?
| | Wrist | 1 | 2017 | 54 | 0.030 |
Why?
| | Lower Extremity | 1 | 2021 | 423 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2002 | 759 | 0.030 |
Why?
| | Plasma | 1 | 2018 | 212 | 0.030 |
Why?
| | Methods | 1 | 1996 | 65 | 0.030 |
Why?
| | Materials Testing | 1 | 2018 | 356 | 0.030 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2016 | 8 | 0.030 |
Why?
| | Self Disclosure | 1 | 1996 | 63 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 1996 | 42 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 2022 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1109 | 0.030 |
Why?
| | Smartphone | 1 | 2016 | 91 | 0.030 |
Why?
| | Carbon Isotopes | 1 | 1996 | 144 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2016 | 364 | 0.030 |
Why?
| | Nontherapeutic Human Experimentation | 1 | 2014 | 4 | 0.030 |
Why?
| | Disease Models, Animal | 3 | 2011 | 4282 | 0.030 |
Why?
| | Support Vector Machine | 1 | 2014 | 38 | 0.030 |
Why?
| | Child | 3 | 2024 | 21822 | 0.030 |
Why?
| | Peptides | 1 | 2019 | 980 | 0.030 |
Why?
| | Machine Learning | 1 | 2018 | 487 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 2067 | 0.030 |
Why?
| | Risk Factors | 2 | 2020 | 10326 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 15504 | 0.030 |
Why?
| | Interviews as Topic | 1 | 1996 | 772 | 0.020 |
Why?
| | Bicycling | 1 | 2013 | 114 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1062 | 0.020 |
Why?
| | Anabolic Agents | 1 | 2012 | 12 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 283 | 0.020 |
Why?
| | United States | 2 | 2020 | 14691 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 752 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1501 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2014 | 423 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 2052 | 0.020 |
Why?
| | Oxygen | 1 | 2016 | 930 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2019 | 2831 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2014 | 806 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2011 | 241 | 0.020 |
Why?
| | Transcription Factors | 1 | 2019 | 1718 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2829 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2012 | 224 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2014 | 575 | 0.020 |
Why?
| | Fourier Analysis | 1 | 2009 | 40 | 0.020 |
Why?
| | Hydrostatic Pressure | 1 | 2009 | 18 | 0.020 |
Why?
| | Electric Impedance | 1 | 2009 | 107 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1146 | 0.020 |
Why?
| | Body Height | 1 | 2009 | 199 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2005 | 333 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 201 | 0.010 |
Why?
| | Mice | 1 | 2019 | 17757 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2822 | 0.010 |
Why?
|
|
Melanson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|